Literature DB >> 20033742

Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population.

Kerang Zhang1, Chunxia Yang, Yong Xu, Ning Sun, Hong Yang, Jinli Liu, Qi Xu, Yan Shen.   

Abstract

Alterations in brain-derived neurotrophic factor (BDNF)-signaling pathways may play an important role in the pathophysiology of major depressive disorder (MDD). Several lines of evidence have suggested that gene-gene interactions may confer susceptibility to MDD. The aim of this study was to analyze the single and combined effects of genes in the BDNF signal-transduction pathway on MDD in a Chinese population. We recruited 447 patients with MDD and 432 age- and gender-matched control subjects. Five SNPs in three BDNF signal-transduction pathway genes (BDNF, GSK3B and AKT1) were used in association analyses. An allelic association between the GSK3B SNP rs6782799 and MDD was found in our sample (allelic: chi(2) = 5.24, P = 0.022, corrected P = 0.107; genotypic: chi(2) = 5.55, P = 0.062) with an odds ratio (OR) of 1.25 (95% confidence interval (CI) 1.03-1.52). Further gene-gene interaction analyses showed a significant effect of a two-locus BDNF/GSK3B interaction with MDD (GSK3B rs6782799 and BDNF rs7124442) (corrected P = 0.011), and also for a three-locus interaction (GSK3B rs6782799, BDNF rs6265 and BDNF rs7124442) (corrected P = 0.019). Individuals carrying the combination of two risk alleles showed an OR value of 4.00 (95% CI 2.05-7.79), while those with the combination of three risk alleles gave the largest OR value of 4.46 (95% CI 2.15-9.24). Taken together, these findings support the assertion that the GSK3B gene is an important susceptibility factor for MDD in a Han Chinese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033742     DOI: 10.1007/s00702-009-0360-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  47 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Analysis of a cluster of polymorphisms in AKT1 gene in bipolar pedigrees: a family-based association study.

Authors:  Tomoko Toyota; Kazuo Yamada; Sevilla D Detera-Wadleigh; Takeo Yoshikawa
Journal:  Neurosci Lett       Date:  2003-03-13       Impact factor: 3.046

3.  Pedigree disequilibrium tests for multilocus haplotypes.

Authors:  Frank Dudbridge
Journal:  Genet Epidemiol       Date:  2003-09       Impact factor: 2.135

4.  Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.

Authors:  Roberta Zanardini; Anna Gazzoli; Mariacarla Ventriglia; Jorge Perez; Stefano Bignotti; Paolo Maria Rossini; Massimo Gennarelli; Luisella Bocchio-Chiavetto
Journal:  J Affect Disord       Date:  2006-01-31       Impact factor: 4.839

5.  A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression.

Authors:  Francesco Benedetti; Alessandro Serretti; Cristina Colombo; Cristina Lorenzi; Viviana Tubazio; Enrico Smeraldi
Journal:  Neurosci Lett       Date:  2004-09-23       Impact factor: 3.046

6.  Family history of depression is associated with younger age of onset in patients with recurrent depression.

Authors:  F Tozzi; I Prokopenko; J D Perry; J L Kennedy; A D McCarthy; F Holsboer; W Berrettini; L T Middleton; H D Chilcoat; P Muglia
Journal:  Psychol Med       Date:  2008-02-13       Impact factor: 7.723

7.  BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents.

Authors:  Lian Mai; Richard S Jope; Xiaohua Li
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

8.  Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders.

Authors:  Alessandro Serretti; Francesco Benedetti; Laura Mandelli; Raffaella Calati; Barbara Caneva; Cristina Lorenzi; Valentina Fontana; Cristina Colombo; Enrico Smeraldi
Journal:  Psychiatry Res       Date:  2007-10-31       Impact factor: 3.222

9.  Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder.

Authors:  S-J Tsai; Y-J Liou; C-J Hong; Y W-Y Yu; T-J Chen
Journal:  Pharmacogenomics J       Date:  2008-01-15       Impact factor: 3.550

10.  The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.

Authors:  Luciana Ribeiro; João V Busnello; Rita M Cantor; Fiona Whelan; Pamela Whittaker; Panos Deloukas; Ma-Li Wong; Julio Licinio
Journal:  Neuroreport       Date:  2007-08-06       Impact factor: 1.837

View more
  16 in total

1.  Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.

Authors:  Orna Levran; Einat Peles; Matthew Randesi; Xu Shu; Jurg Ott; Pei-Hong Shen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2013-05       Impact factor: 2.533

2.  Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation.

Authors:  Shusuke Numata; Kazuo Ishii; Atsushi Tajima; Jun-ichi Iga; Makoto Kinoshita; Shinya Watanabe; Hidehiro Umehara; Manabu Fuchikami; Satoshi Okada; Shuken Boku; Akitoyo Hishimoto; Shinji Shimodera; Issei Imoto; Shigeru Morinobu; Tetsuro Ohmori
Journal:  Epigenetics       Date:  2015-01-14       Impact factor: 4.528

3.  Topiramate via NMDA, AMPA/kainate, GABAA and Alpha2 receptors and by modulation of CREB/BDNF and Akt/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Sulail Fatima; Tabassom Beiranvand; Shiva Mozaffari
Journal:  J Neural Transm (Vienna)       Date:  2017-08-09       Impact factor: 3.575

Review 4.  Molecular and genetic basis of depression.

Authors:  Madhumita Roy; Madhu G Tapadia; Shobhna Joshi; Biplob Koch
Journal:  J Genet       Date:  2014-12       Impact factor: 1.166

5.  Brain-derived neurotrophic factor gene polymorphisms, neurotransmitter levels, and depressive symptoms in an elderly population.

Authors:  Maria E Czira; Heike Wersching; Bernhard T Baune; Klaus Berger
Journal:  Age (Dordr)       Date:  2011-09-07

6.  Possible association of the GSK3β gene with the anxiety symptoms of major depressive disorder and P300 waveform.

Authors:  Sha Liu; Ning Sun; Yong Xu; Chunxia Yang; Yan Ren; Zhifen Liu; Xiaohua Cao; Yan Sun; Qi Xu; Kerang Zhang; Yan Shen
Journal:  Genet Test Mol Biomarkers       Date:  2012-10-02

7.  Assessment of genetic and nongenetic interactions for the prediction of depressive symptomatology: an analysis of the Wisconsin Longitudinal Study using machine learning algorithms.

Authors:  Nicholas S Roetker; C David Page; James A Yonker; Vicky Chang; Carol L Roan; Pamela Herd; Taissa S Hauser; Robert M Hauser; Craig S Atwood
Journal:  Am J Public Health       Date:  2013-08-08       Impact factor: 9.308

8.  No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis.

Authors:  Joseph P Gyekis; Weihong Yu; Shuqian Dong; Haina Wang; Jun Qian; Pravina Kota; Jingyun Yang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-11-26       Impact factor: 3.568

9.  Genetic biomarkers of depression.

Authors:  Anand Tamatam; Farhath Khanum; Amarinder Singh Bawa
Journal:  Indian J Hum Genet       Date:  2012-01

10.  Prioritization and evaluation of depression candidate genes by combining multidimensional data resources.

Authors:  Chung-Feng Kao; Yu-Sheng Fang; Zhongming Zhao; Po-Hsiu Kuo
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.